Covid: 75N93021D00021 cerba research sars-COV-2 support base award split cans can 8042185 $691,249.07 can 8049059 $691,249.07 total $1,382,498.14
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Cerba Research Usa, Inc. UEI W15NDJ1DSXN9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,615,094
Award facts
- Contract value 100% obligated
- $1,615,094.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New Hyde Park, NY 11042, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $36,596 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $196,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,382,498 |
About this award
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Cerba Research USA, Inc. for SARS-CoV-2 testing support. The total award value is $1,382,498.14, with a total ceiling of $1,615,094.14. The period of performance runs through December 31, 2023. This award is not associated with a larger contract vehicle, and no set-aside designation was used. Cerba Research USA, Inc. is a for-profit organization that provides clinical trial and laboratory services to support biomedical research, and has received previous awards from NIAID, the National Human Genome Research Institute, and the National Cancer Institute.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Cerba Research Usa, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 13, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $1,615,094 on 75N93022F00001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93021D00021, an indefinite delivery contract.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award